or Try an Advanced Search...

    Technical Analysis for INTS - Intensity Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 3.68 0.27% 0.01
    INTS closed up 0.27 percent on Friday, September 22, 2023, on 35 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A Down Down
    Historical INTS trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.27%
    Calm After Storm Range Contraction 0.27%
    Lower Bollinger Band Walk Weakness 0.27%
    Older End-of-Day Signals for INTS ...

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    INTS Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company’s technology and products.
    Classification
    Sector: Other
    Industry: Other
    Keywords: Biotechnology Biopharmaceutical Pharmacy Chemotherapy

    Is INTS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 7 Intensity Therapeutics nabs FDA orphan drug tag for cancer therapy
    Aug 14 Earnings Scheduled For August 14, 2023
    Aug 7 Intensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update
    Jul 31 Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business Update
    Jun 30 Intensity Therapeutics stock jumps 18% following $20M IPO
    See more INTS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.75
    52 Week Low 3.62
    Average Volume 21,673
    200-Day Moving Average 0.00
    50-Day Moving Average 5.62
    20-Day Moving Average 5.02
    10-Day Moving Average 4.43
    Average True Range 0.33
    RSI (14) 13.79
    ADX 60.61
    +DI 2.57
    -DI 39.42
    Chandelier Exit (Long, 3 ATRs) 5.00
    Chandelier Exit (Short, 3 ATRs) 4.60
    Upper Bollinger Bands 6.51
    Lower Bollinger Band 3.53
    Percent B (%b) 0.05
    BandWidth 59.35
    MACD Line -0.54
    MACD Signal Line -0.38
    MACD Histogram -0.1575
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.82
    Resistance 3 (R3) 3.81 3.76 3.79
    Resistance 2 (R2) 3.76 3.73 3.76 3.78
    Resistance 1 (R1) 3.72 3.70 3.74 3.73 3.78
    Pivot Point 3.67 3.67 3.68 3.67 3.67
    Support 1 (S1) 3.63 3.64 3.65 3.64 3.58
    Support 2 (S2) 3.58 3.61 3.58 3.58
    Support 3 (S3) 3.54 3.58 3.57
    Support 4 (S4) 3.55